Endogenous enkephalins and reward mechanisms
内源性脑啡肽和奖励机制
基本信息
- 批准号:10203896
- 负责人:
- 金额:$ 30.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAddressAffectAffinityAmericanBehaviorBehavioralBehavioral MechanismsBindingBrainChronicChronic DiseaseCocaineCocaine DependenceComplexCorpus striatum structureCuesDataDevelopmentDopamineDrug AddictionDrug ControlsEnkephalinsFemaleFutureGlutamatesGoalsHealthKnowledgeLeadLearningLifeLigandsMass Spectrum AnalysisMeasurementMediatingMediator of activation proteinMicrodialysisMissionMotivationNeurobiologyNeurotransmittersNucleus AccumbensOpioidPathway interactionsPharmaceutical PreparationsPharmacologyPlayProceduresProcessPropertyPsychological reinforcementReceptor ActivationReceptor SignalingRelapseReportingResearchRewardsRoleSamplingSex DifferencesSiteSocietiesStimulusSystemTechniquesTimeUnited States National Institutes of HealthWood materialWorkaddictionbasebehavior measurementdelta opioid receptordesigndrug cravingdrug developmentdrug of abusedrug relapseendogenous opioidsexperimental studyin vivoinnovationknock-downmaleneural circuitneurobiological mechanismneurochemistrynovelpaired stimulipleasurepreventreinforcerresponsesmall hairpin RNA
项目摘要
Project Summary/Abstract
There are fundamental gaps in our understanding of the neurobiological processes involved in addiction, in
particular the complex changes produced by drug-paired cues (conditioned reinforcers) that increase drug-taking
behavior and provoke relapse. Identifying novel mechanisms by which conditioned reinforcers modify behavior
is essential for future efforts to design new treatments to control drug craving and prevent relapse to addiction.
The long-term goal of this work is to further our understanding of the behavioral and neurobiological mechanisms
mediating drug-paired stimuli that serve as conditioned reinforcers. The objective of this application is to identify
the role of the endogenous enkephalinergic system in regulating the reinforcing properties of cocaine-associated
stimuli that are an essential part of cocaine addiction. Enkephalins binds with high affinity to delta-opioid
receptors (DOPRs), which are highly expressed within the reward pathway, and DOPR activation can alter
responding for drug-paired cues without primary reinforcing effects. Our overarching hypothesis is that
enkephalins acting at delta-opioid receptors (DOPRs) in the nucleus accumbens shell (NAc-S) play an essential
role in the behavioral and neurochemical mechanisms mediating the conditioned reinforcing properties of
cocaine-paired cues. This proposal will couple behavioral measurements of conditioned reinforcement with in
vivo microdialysis and comprehensive mass spectrometry analysis to evaluate in real-time the role of the
enkephalin and DOPRs in establishing and maintaining the salience of cocaine-associated cues. Through the
innovative use of behavioral and neurochemical measurement techniques, this proposal will expand beyond the
status quo to investigate novel mechanisms selectively mediating conditioned reinforcement but not necessarily
the direct, primary reinforcing effects of cocaine. Ultimately, such knowledge has the potential to develop new
treatments for preventing relapse.
项目总结/摘要
我们对成瘾的神经生物学过程的理解存在根本性的差距,
特别是药物配对线索(条件反射)产生的复杂变化,
行为并引发复发。确定条件反射改变行为的新机制
对于未来设计新的治疗方法来控制药物渴望和防止成瘾复发至关重要。
这项工作的长期目标是进一步了解行为和神经生物学机制
介导作为条件反射剂的药物配对刺激。本申请的目的是确定
内源性脑啡肽能系统在调节可卡因相关的增强特性中的作用
这些刺激是可卡因成瘾的重要组成部分。脑啡肽以高亲和力与δ-阿片样物质结合
受体(DOPR),这是高度表达的奖励途径,和DOPR激活可以改变
对药物配对线索的反应,而没有主要的强化作用。我们的首要假设是
脑啡肽作用于延髓核壳(NAc-S)中的δ阿片受体(DOPR),
在行为和神经化学机制中的作用,
可卡因配对线索这项建议将耦合行为测量条件强化与在
体内微透析和综合质谱分析,以实时评估
脑啡肽和DOPR在建立和维持可卡因相关线索的显著性方面的作用。通过
行为和神经化学测量技术的创新使用,这一建议将扩大超越
研究选择性介导条件强化的新机制,但不一定
可卡因的直接的、主要的强化作用。最终,这些知识有可能开发新的
预防复发的治疗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMILY M JUTKIEWICZ其他文献
EMILY M JUTKIEWICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMILY M JUTKIEWICZ', 18)}}的其他基金
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10221663 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10159424 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10026089 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10672930 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
9894965 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10449233 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesics
开发G蛋白βγ亚基抑制剂以提高阿片类镇痛药的安全性和有效性
- 批准号:
10448677 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Abuse potential of a novel bifunctional opioid ligand
新型双功能阿片类配体的滥用潜力
- 批准号:
9245248 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
Abuse potential of a novel bifunctional opioid ligand
新型双功能阿片类配体的滥用潜力
- 批准号:
9419813 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.67万 - 项目类别:
Research Grant














{{item.name}}会员




